Dyloject

Discussion in 'Pfizer' started by anonymous, Feb 26, 2016 at 10:14 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest


  2. anonymous

    anonymous Guest

  3. anonymous

    anonymous Guest

    this is not a viable product. it will never be used. total sales from launch to expiration of patent will not even be 10 million
    I say sales under a million from launch to end of this year.
    next year under 1.3 million
    2018 under 1.6 million
    How does Pfizer not know this. The division would be more profitable not selling it.
    The cost of the sales aids are more then any sales the company can ever hope to gain.
    Every month I just laugh in amazement that this continues. It is almost criminal that funds and resources are allocated to this product.
     
  4. anonymous

    anonymous Guest

    yeah but when you have a slick MBA JD PharmD (that can't even spell patient) slick back Porsche driving, PT dazzling running the Dyloject shitshow-sure to be successful
     
  5. anonymous

    anonymous Guest

     
  6. anonymous

    anonymous Guest

    Drill down into his CV. Bet half of it is fake. Inherited money. Dont be fooled by the bling; any fool can use a credit card. If this fool is behind this shit, he can't be worth much.